Considerations for Improving High to Low Dose Extrapolation for Regulatory Risk Assessment

Click to increase image sizeClick to decrease image size

ACKNOWLEDGEMENTS

I would like to thank Adam Finkel, Tracey Woodruff and George Alexeeff for their thoughtful comments and suggestions.

The views expressed do not necessarily represent those of the Office of Environmental Health Hazard Assessment, the California Environmental Protection Agency, or the State of California.

This work is a product of the U.S. Government and is not copyrighted.

Notes

^*For mutagenic carcinogens adjustments are made to address potential susceptibility in infancy and childhood, but not in utero.